Skip to content

NBTX

Nanobiotix SA

NASDAQ · Healthcare · Biotechnology · FR

$33.05
−7.89%
Ask drillr

Next report

Analyst consensus

Next report date
Sep 29, 2026
EPS estimate
-$0.48
Revenue estimate
$1.7M

Latest reported

Last report date
Mar 31, 2026
EPS actual
-$0.46
EPS estimate
$0.30
Revenue actual
$3.5M
Revenue estimate
$51.5M

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
-79.0%
Revenue beats (12Q)
2
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Mar 31, 2026$0.30-$0.46Miss -250.74%$3.5M
Sep 30, 2025-$0.25-$0.13Beat 45.89%$31.4M
Apr 2, 2025-$0.62-$1.01Miss -63.46%-$21.6M
Nov 13, 2023-$0.59-$0.87Miss -47.60%$3.6M
May 5, 2021-$1.01-$0.57Beat 43.06%$15.9K
Oct 23, 2020-$1.09-$1.02Beat 5.92%
Apr 30, 2020-$1.37$35.2K
Dec 31, 2018-$1.08$1.7M
Jun 30, 2016-$0.76$3.4M
Jun 30, 2015-$0.58$1.8M
Dec 31, 2014-$0.50$2.3M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 29, 2026